Amanote Research
Register
Sign In
Pembrolizumab Yields Lasting Merkel Cell Carcinoma Responses
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-nb2016-050
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
April 20, 2016
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Merkel Cell Carcinoma
American Journal of Clinical Oncology: Cancer Clinical Trials
Cancer Research
Oncology
Merkel Cell Carcinoma
Mayo Clinic Proceedings
Medicine
P29. T-Cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Merkel Cell Carcinoma Patients From Healthy Donors
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
T-Cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients With Merkel Cell Carcinoma From Healthy Donors
Clinical Cancer Research
Cancer Research
Oncology
Rescue of Immunotherapy-Refractory Metastatic Merkel Cell Carcinoma With Conventionally Fractionated Radiotherapy and Concurrent Pembrolizumab
Frontiers in Oncology
Cancer Research
Oncology
Merkel Cell Polyomavirus DNA in Persons Without Merkel Cell Carcinoma
Emerging Infectious Diseases
Epidemiology
Infectious Diseases
Microbiology
Merkel Cell Carcinoma: Literature Review
Nowotwory
Cancer Research
Oncology
Merkel Cell Carcinoma Subgroups by Merkel Cell Polyomavirus DNA Relative Abundance and Oncogene Expression
International Journal of Cancer
Cancer Research
Oncology
Merkel Cell Carcinoma: Update and Review
Seminars in Cutaneous Medicine and Surgery
Dermatology
Medicine
Surgery